MacroGenics Statistics

Total Valuation

MacroGenics has a market cap or net worth of $191.32 million. The enterprise value is $38.16 million.

Market Cap	191.32M
Enterprise Value	38.16M

Important Dates

The next estimated earnings date is Friday, May 8, 2026, after market close.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

MacroGenics has 63.56 million shares outstanding. The number of shares has increased by 0.85% in one year.

Current Share Class	63.56M
Shares Outstanding	63.56M
Shares Change (YoY)	+0.85%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	2.58%
Owned by Institutions (%)	53.16%
Float	55.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.28
Forward PS	2.34
PB Ratio	3.43
P/TBV Ratio	3.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.26
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.10, with a Debt / Equity ratio of 0.66.

Current Ratio	5.10
Quick Ratio	4.71
Debt / Equity	0.66
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-8.56

Financial Efficiency

Return on equity (ROE) is -86.95% and return on invested capital (ROIC) is -37.03%.

Return on Equity (ROE)	-86.95%
Return on Assets (ROA)	-17.56%
Return on Invested Capital (ROIC)	-37.03%
Return on Capital Employed (ROCE)	-34.08%
Weighted Average Cost of Capital (WACC)	11.57%
Revenue Per Employee	$510,239
Profits Per Employee	-$254,676
Employee Count	293
Asset Turnover	0.58
Inventory Turnover	n/a

Taxes

Income Tax	-672,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +76.02% in the last 52 weeks. The beta is 1.10, so MacroGenics's price volatility has been similar to the market average.

Beta (5Y)	1.10
52-Week Price Change	+76.02%
50-Day Moving Average	2.81
200-Day Moving Average	1.93
Relative Strength Index (RSI)	44.38
Average Volume (20 Days)	744,123

Short Selling Information

The latest short interest is 2.93 million, so 4.61% of the outstanding shares have been sold short.

Short Interest	2.93M
Short Previous Month	3.78M
Short % of Shares Out	4.61%
Short % of Float	5.27%
Short Ratio (days to cover)	3.27

Income Statement

In the last 12 months, MacroGenics had revenue of $149.50 million and -$74.62 million in losses. Loss per share was -$1.18.

Revenue	149.50M
Gross Profit	-33.68M
Operating Income	-72.84M
Pretax Income	-75.29M
Net Income	-74.62M
EBITDA	-65.67M
EBIT	-72.84M
Loss Per Share	-$1.18

Full Income Statement

Balance Sheet

The company has $189.91 million in cash and $36.76 million in debt, giving a net cash position of $153.15 million or $2.41 per share.

Cash & Cash Equivalents	189.91M
Total Debt	36.76M
Net Cash	153.15M
Net Cash Per Share	$2.41
Equity (Book Value)	55.59M
Book Value Per Share	0.88
Working Capital	176.83M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$81.04 million and capital expenditures -$1.91 million, giving a free cash flow of -$82.95 million.

Operating Cash Flow	-81.04M
Capital Expenditures	-1.91M
Depreciation & Amortization	7.17M
Net Borrowing	n/a
Free Cash Flow	-82.95M
FCF Per Share	-$1.31

Full Cash Flow Statement

Margins

Gross margin is -22.53%, with operating and profit margins of -48.72% and -49.91%.

Gross Margin	-22.53%
Operating Margin	-48.72%
Pretax Margin	-50.36%
Profit Margin	-49.91%
EBITDA Margin	-43.93%
EBIT Margin	-48.72%
FCF Margin	n/a

Dividends & Yields

MacroGenics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.85%
Shareholder Yield	-0.85%
Earnings Yield	-39.00%
FCF Yield	-43.36%

Analyst Forecast

The average price target for MacroGenics is $5.00, which is 66.11% higher than the current price. The consensus rating is "Buy".

Price Target	$5.00
Price Target Difference	66.11%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	17.10%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MacroGenics has an Altman Z-Score of -5.97 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.97
Piotroski F-Score	3